홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Fosaprepitant

HCID 135413538
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
172673-20-0
표준 SMILES
C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
InChIKey
BARDROPHSZEBKC-OITMNORJSA-N
분자식
C23H22F7N4O6P
평균 분자량
614.4 g/mol
단동위원소 질량
614.11651857

개요

Fosaprepitant is a morpholine derivative that is the (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl ether of (3-{[(2R,3S)-3-(4-fluorophenyl)-2-hydroxymorpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid. It has a role as a prodrug, an antiemetic and a neurokinin-1 receptor antagonist. It is a phosphoramide, a member of triazoles, a member of morpholines, a cyclic acetal and a member of (trifluoromethyl)benzenes. It is a conjugate acid of a fosaprepitant(2-).

이름 및 식별자

우선 이름
Fosaprepitant
IUPAC
[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4H-1,2,4-triazol-1-yl]phosphonic acid
영어명
Fosaprepitant
분자식
C23H22F7N4O6P
분자량
614.41

이름 및 동의어

Fosaprepitant172673-20-0fosaprepitantum6L8OF9XRDCL-758298L-758,298(3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acidCHEBI:64321DTXSID801021651L785,298(3-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)MORPHOLIN-4-YL)METHYL)-5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-1-YL)PHOSPHONIC ACID(3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid
이름 더 보기
FoxapitanFosaprepitant D4MK-0517 (Fosaprepitant)Fosaprepitant See F727305Fosaprepitant (See also F727305)[3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonic acidP-[3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-Morpholinyl]Methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonic Acid

물성

구조 계산 물성보충 중

XLogP
1
극성 표면적
124 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
15
회전 가능 결합 수
7
무거운 원자 수
41
형식 전하
0
복잡도
997

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Alimentary tract and metabolism -> Antiemetics and antinauseants

Pharmaceuticals -> Listed in ZINC15

Human DrugsEMA approved medicines: Human medicine
Physical DescriptionSolid

물리화학적 성질

녹는점
74 °C · >74°C (dec.)
밀도
1.65 · 1.65
저장 조건
-20 °C · Inert atmosphere,Store in freezer, under -20°C
용해도
DMSO및메탄올에 용해됨
산도 계수 (pKa)
2.45 · 2.45±0.20(Predicted)
물리적 상태
고체
색상
하얀색
InChIKey
BARDROPHSZEBKC-OITMNORJSA-N
SMILES
P(N1C(=O)N=C(CN2CCO[C@H](O[C@@H](C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)C)[C@@H]2C2=CC=C(F)C=C2)N1)(=O)(O)O

화학적 성질

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 데이터

신호 어
Warning
유해·위험 문구
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H302

화학 및 산업

약리 정보

Protein Binding95% +
Pharmacodynamics · 1건

Fosaprepitant is a prodrug of Aprepitant. Once biologically activated, the drug acts as a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT<sub>3</sub>), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting (CI NV).

Mechanism of Action · 1건

Aprepitant has been shown in animal models to inhibit emesis induced by cytotoxic chemotherapeutic agents, such as cisplatin, via central actions. Animal and human Positron Emission Tomography (PET) studies with Aprepitant have shown that it crosses the blood brain barrier and occupies brain NK1 receptors. Animal and human studies show that Aprepitant augments the antiemetic activity of the 5-HT<sub>3</sub>-receptor antagonist ondansetron and the corticosteroid ethasone and inhibits both the acute and delayed phases of cisplatin induced emesis. In summary, the active form of fosaprepitant is as an NK1 antagonist which is because it blocks signals given off by NK1 receptors. This therefore decreases the likelihood of vomiting in patients experiencing.

Biological Half-Life9-13 hours
Metabolism/MetabolitesAprepitant is metabolized primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19. Seven metabolites of aprepitant, which are only weakly active, have been identified in human plasma.
FDA Pharmacological Classification · 6건

6L8OF9XRDC

FOSAPREPITANT

Mechanisms of Action [MoA] - Neurokinin 1 Antagonists

Established Pharmacologic Class [EPC] - Substance P/Neurokinin-1 Receptor Antagonist

Fosaprepitant is a Substance P/Neurokinin-1 Receptor Antagonist. The mechanism of action of fosaprepitant is as a Neurokinin 1 Antagonist.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
(3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-5-oxo-2H-1,2,4-triazol-1-yl)phosphonic acid(3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-2H-1,2,4-triazol-1-yl]phosphonic acidRefChem:57105DTXCID801506659L 758298emend(R) IVFosaprepitant [INN]

데이터베이스 식별자

CAS
172673-20-0
PubChem CID
135413538
DTXSID
DTXSID801021651
ChEMBL
CHEMBL1199324
ChEBI
CHEBI:64321
UNII
6L8OF9XRDC
Nikkaji
J1.291.580B

White Solid

FOSAPREPITANT

MeSH Pharmacological Classification · 2건

Drugs used to prevent NAUSEA or VOMITING.

Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS.

Absorption, Distribution and ExcretionAprepitant is eliminated primarily by metabolism; aprepitant is not renally excreted. Aprepitant is excreted in the milk of rats. It is not known whether this drug is excreted in human milk.
Cellular LocationsMembrane

응용 분야

용도Fosaprepitant is a selective neurokinin-1 (NK-1) receptor antahonist. Fosaprepitant is an antiemetic drug, a Aprepitant (A729800) prodrug.

추가 설명

정의ChEBI: A morpholine derivative that is the (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl ether of (3-{[(2R,3S)-3-(4-fluorophenyl)-2-hydroxymorpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triaz l-1-yl)phosphonic acid.